This review summarizes articles that have been reported in literature on liposome-based
strategies for effective drug delivery across the blood–brain barrier. Due to their unique …

Nanotechnology takes the lead in providing new therapeutic options for cancer patients. In
the last decades, lipid-based nanoparticles—solid lipid nanoparticles (SLNs) …

Translation of novel therapies for brain cancer into clinical practice is of the utmost
importance as primary brain tumors are responsible for more than 200,000 deaths …

Primary brain and central nervous system (CNS) tumors are a diverse group of neoplasms
that occur within the brain and spinal cord. Although significant advances in our …

Cisplatin (Cis) is a widely used chemotherapeutic drug for cancer treatment. However,
toxicities and drug resistance limit the use of cisplatin. This study was aimed to improve …

The use of antibody-conjugated nanoparticles for brain tumor treatment has gained
significant attention in recent years. Nanoparticles functionalized with anti-transferrin …

The products of oleaginous microbes, primarily lipids, have gained tremendous attention for
their health benefits in food-based applications as supplements. However, this emerging …

Targeted delivery of anticancer drugs to brain tumors, especially glioblastoma multiforme,
which is the most frequent and aggressive type, is one of the important objectives in …

Therapeutic conveyance into the brain is a cardinal requirement for treatment of diverse
central nervous system (CNS) disorders and associated pathophysiology. Effectual …

Besides being indispensable for the protection and nutrition of the central nervous system
(CNS), blood-brain barrier (BBB)-forming cerebral endothelial cells (CECs) have a major …